List view / Grid view
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Until now, the time-consuming marketing authorisation process was the only path to being able to market products containing St John’s Wort and Valerian...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
In July, Sanofi revealed the development agreement with the Walter Reed Army Institute of Research on the co-development of a Zika vaccine candidate...
27 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Also known as "Butterfly skin" syndrome, epidermolysis bullosa (EB) is a rare genetic skin disease that is caused by the absence of a gene (COL7A1)...
26 September 2016 | By Edinburgh Instruments
Researchers at North Carolina State University, led by Prof. Felix Castellano, have shown for the first time that the photogenerated triplet exciton in semiconductor nanocrystals can be harvested by surface bound molecular acceptors, exhibited by a six-order magnitude increase in the lifetime of the originally prepared excited state...
23 September 2016 | By Wickham Laboratories Limited
Wickham Laboratories is pleased to introduce stability storage and testing as its latest service offering...
23 September 2016 | By Wickham Laboratories Limited
Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection by hydrogen peroxide...
23 September 2016 | By BBI Solutions
BBI Solutions has launched Morffi™, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September...
23 September 2016 | By CI Precision
Global consumer goods group RB (formerly known as Reckitt Benckiser) is implementing CI Precision’s MES solution (Ci-DMS) in the dispensing area at their manufacturing plant in Pakistan...
21 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Fewer serious adverse events were seen with semaglutide vs placebo; however, treatment discontinuation due to adverse events was more frequent...
21 September 2016 | By Coulter Partners
Global Life Sciences search specialist, Coulter Partners is pleased to announce a number of new appointments in the US and in London...
21 September 2016 | By Niamh Louise Marriott, Digital Content Producer
T-Guard has been shown to be well tolerated, with a manageable side effect profile and no severe infusion reactions in patients with acute GVHD...
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
She will succeed Andrew Witty as GSK CEO, when he retires on 31st March 2017. She will be the first female CEO of a major global pharmaceuticals company...
20 September 2016 | By WHEATON®
New line of purpose-built, ready-to-sterilize, uniquely barcoded vials will be introduced at the American Association of Clinical Chemistry Annual Meeting...
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
This study was the first in man Phase 1 clinical trial for an mGluR4 positive allosteric modulator. The randomised, double-blind, placebo controlled single and multiple ascending dose studies were designed to assess safety and tolerability of PXT002331 dosed orally...
20 September 2016 | By Edinburgh Instruments
Research in optical materials is rapidly moving towards stable, high-power laser sources emitting in the mid-infrared (mid-IR) region...
